featured
Severe Disease Reactivation in Patients With Seropositive NMOSD After Stopping Eculizumab Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment
Mult Scler Relat Disord 2023 Aug 25;79(xx)104949, S Sen, A Tuncer, M Terzi, SD Bunul, P Ozen-Acar, B Altunrende, S Ozakbas, M Tutuncu, U Uygunoglu, G Akman-Demir, R Karabudak, H Efendi, A SivaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.